MarketPeel
Insider Trading Intelligence
JG

Jason Grady

IBO
DIRECTOR · IMPACT BIOMEDICAL INC. · CIK 0001782482
FILING MIX · LIFETIME0%/100%
BUYS
0
SELLS
1
TOTAL VALUE
$32.5K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
250,182
AVG SELL PX
$0.65
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Jason Grady, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-9.58%-3.57%-6.01%-6.01%
14d1+100.00%-1.08%+0.54%-1.62%-1.62%
30d1+0.00%+2.01%+8.52%-6.51%-6.51%
60d1+100.00%-18.80%
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 0 buys / 1 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
IBO
IMPACT BIOMEDICAL INC.
SALE
50,000$0.65$32.5K250,182Mar 23, 2026Mar 25, 2026
Other insiders · IBO
Loading peer insiders…
About this filer
CIK 0001782482
ROLE
Director
PRIMARY
IBO
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0001782482DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback